British scientists believe they have found specific patterns of brain activity in children and young people which could be signs or "markers" of those who will later go on to develop mental illnesses such as schizophrenia.
British scientists believe they have found specific patterns of brain activity in children and young people which could be signs or "markers" of those who will later go on to develop mental illnesses such as schizophrenia.
British scientists believe they have found specific patterns of brain activity in children and young people which could be signs or "markers" of those who will later go on to develop mental illnesses such as schizophrenia. Schizophrenia - Mental disorder - Mental health - Health - Brain
Posted by Vyvanse In the News on at
Filed under Vyvanse News · Tagged with Brain Activity, Brain Patterns, British Scientists, Health Health, Mental Disorder, Mental Health, Mental Illness, Mental Illnesses, Risk, Schizophrenia, Schizophrenia Schizophrenia, Signs
British scientists believe they have found specific patterns of brain activity in children and young people which could be signs or "markers" of those who will later go on to develop mental illnesses such as schizophrenia.
Dainippon Sumitomo Pharma America, Inc. (DSPA), a U.S. subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP), submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for lurasidone, an investigational atypical antipsychotic agent for the treatment of schizophrenia. The application, submitted on December 30, 2009, includes data from more than 40 clinical studies ...
Posted by Vyvanse In the News on at
Filed under Vyvanse News · Tagged with Antipsychotic Agent, Dainippon Sumitomo, Drug Application, Dsp, Dspa, Fda, Fda News, Food And Drug, Food And Drug Administration, Food And Drug Administration Fda, Lurasidone, Nda, Pharma, Schizophrenia, Subsidiary, Sumitomo, Treatment Of Schizophrenia